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Osteoarthritis (OA) is a painful and debilitating condition of
synovial joints without any disease-modifying therapies [A. M.
Valdes, T. D. Spector, Nat. Rev. Rheumatol. 7, 23–32 (2011)]. We
previously identified mechanosensitive PIEZO channels, PIEZO1
and PIEZO2, both expressed in articular cartilage, to function in
chondrocyte mechanotransduction in response to injury [W. Lee
et al., Proc. Natl. Acad. Sci. U.S.A. 111, E5114–E5122 (2014); W.
Lee, F. Guilak, W. Liedtke, Curr. Top. Membr. 79, 263–273 (2017)].
We therefore asked whether interleukin-1–mediated inflamma-
tory signaling, as occurs in OA, influences Piezo gene expression
and channel function, thus indicative of maladaptive reprogram-
ming that can be rationally targeted. Primary porcine chondrocyte
culture and human osteoarthritic cartilage tissue were studied. We
found that interleukin-1α (IL-1α) up-regulated Piezo1 in porcine
chondrocytes. Piezo1 expression was significantly increased in hu-
man osteoarthritic cartilage. Increased Piezo1 expression in chon-
drocytes resulted in a feed-forward pathomechanism whereby
increased function of Piezo1 induced excess intracellular Ca2+ at
baseline and in response to mechanical deformation. Elevated
resting state Ca2+ in turn rarefied the F-actin cytoskeleton and
amplified mechanically induced deformation microtrauma. As in-
tracellular substrates of this OA-related inflammatory pathome-
chanism, in porcine articular chondrocytes exposed to IL-1α, we
discovered that enhanced Piezo1 expression depended on
p38 MAP-kinase and transcription factors HNF4 and ATF2/CREBP1.
CREBP1 directly bound to the proximal PIEZO1 gene promoter.
Taken together, these signaling and genetic reprogramming events
represent a detrimental Ca2+-driven feed-forward mechanism that
can be rationally targeted to stem the progression of OA.
osteoarthritis | interleukin-1 | PIEZO1 | Piezo1 gene regulation
Osteoarthritis (OA) is a significant global health issue withincreasing population age as well as rising obesity rates
(1–3). OA is characterized by progressive joint degeneration and
pain, leading to significant disability and lack of mobility that
further aggravates other age-associated conditions. Due to the
multifactorial etiology of the disease and the lack of a full un-
derstanding of OA pathogenesis, there are no disease-modifying
OA drugs (DMOADs) currently available (4, 5). However, growing
evidence has documented increased levels of interleukin-1 (IL-1)–
based inflammatory signaling in chondrocytes, the sole cell pop-
ulation in healthy articular cartilage (6–10). Articular chondrocytes
express functional IL-1 receptor and respond to both isoforms of
IL-1 (α and β) potently through catabolic and antianabolic activities
(11). Mechanical factors, over protracted times through multiple
iterative microtrauma, play a critical role in OA pathogenesis through
alterations in cell-mediated mechanotransduction in cartilage (2,
12–17) and may interact with injurious loading to enhance cartilage
degeneration (18). At the molecular level, we have described the
presence of both mechanosensory Piezo ion channels (PIEZO1 and
PIEZO2) in chondrocytes, which function synergistically in response
to injurious mechanical loading (19). In the present study, we address
the unanswered question whether joint inflammation, as occurs in
OA, affects gene regulation and function of Piezo ion channels as a
propathogenic OA mechanism. We provide affirmative and mecha-
nistic answers on how IL-1α–mediated inflammatory signaling in artic-
ular chondrocytes up-regulates PIEZO1 gene expression and function.
Results
OA-Relevant Levels of Proinflammatory IL-1α Enhance Expression of
PIEZO1. First, we found PIEZO1 messenger RNA (mRNA) was
significantly increased in porcine primary articular chondrocytes
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in response to IL-1α over a range of physiologically and patho-
logically relevant concentrations (Fig. 1A). Dose dependence
was clearly present between control, 0.1 ng/mL, and 1 ng/mL IL-
1α, followed by a plateau of Piezo 1 mRNA levels when com-
paring 1 ng/mL and 10 ng/mL IL-1α. This increase also man-
ifested as elevated PIEZO1 protein expression as shown by
up-regulated PIEZO1 immunolabeling of primary porcine chon-
drocytes and Western blotting (Fig. 1 B and C) using a PIEZO1
antibody that we verified in a human PIEZO1−/− cell line (SI
Appendix, Fig. S1). Expression of PIEZO2 was increased in re-
sponse to IL-1α but not to significant degree (SI Appendix, Fig.
S2). Given the importance of Piezo2 in force sensing, more fo-
cused exploration of its role in OA pathogenesis will be the
subject of future studies, but here we focus on the overtly reg-
ulated Piezo1. We also probed expression of TRPV4, a well-
characterized chondrocyte mechanosensor (20–23), which we
found not to be regulated by IL-1α (SI Appendix, Fig. S2). We
also measured PIEZO1 expression in human cartilage, where we
detected significantly elevated PIEZO1 protein by immunolab-
eling in osteoarthritic cartilage compared to normal controls
(Fig. 1D) again using the validated PIEZO1 antibody. Thus, IL-
1α signaling at OA-relevant concentrations evokes significantly
increased PIEZO1 mRNA expression, a finding confirmed at the
protein level in articular chondrocytes and human osteoarthritic
cartilage lesions. We therefore decided to test PIEZO1 function
by use of Yoda-1, a specific PIEZO1 activator, and Ca2+-imag-
ing (24). In response to Yoda-1, primary porcine chondrocytes
pretreated with IL-1α exhibited enhanced Ca2+ signaling, with a
robustly accelerated signal increase and a resulting vastly in-
creased amount of Ca2+ entering the cell (Fig. 1E). We conclude
that IL-1α inflammatory signaling of articular chondrocytes in-
creases PIEZO1 expression and function in chondrocytes. Building
on this finding, the concept emerges that inflammation deleteriously
predisposes chondrocytes to become more sensitive to injurious
levels of loading. Our finding that TRPV4, a mechanosensor that
transduces physiologic levels of loading in chondrocytes, is not
regulated by IL-1α suggests inflammation selectively alters chon-
drocyte mechanotransduction pathways. Based on this result, we
conducted more in-depth Ca2+-signaling studies in response to
controlled single-cell mechanical stimulation with or without IL-
1α–mediated inflammation.
Piezo1 Increased Expression and Enhanced Function Elevates Baseline
[Ca2+]o and Renders Chondrocytes Mechanically Hypersensitive. Iso-
lated primary porcine chondrocytes were subjected to recording
their steady-state intracellular calcium levels, [Ca2+]o, using
ratiometric Ca2+ imaging in the presence or absence of IL-1α.
Chondrocyte [Ca2+]o increased 37% in the presence of 0.1 ng/mL
IL-1α. However, no further increase in [Ca2+]i was observed
with higher concentration of IL-1α (Fig. 2 A and B). We con-
clude that IL-1α exposure, at 0.1 ng/mL, profoundly changes
articular chondrocytes’ functional state by increasing basal steady-
state [Ca2+]o by >30%, and that in our in vitro system, there is an
exquisite sensitivity of the chondrocytes to sub-ng/ml concentra-
tions of IL-1α, perhaps indicative of chondrocyte vulnerability in
early stages of OA. We next conducted controlled compression of
isolated chondrocytes, using atomic force microscopy (AFM), with
a tipless cantilever to exert dynamic loading of 300 nN at a rate of
1 μm/s ramp-speed and ramps every 10 s, while simultaneously
recording [Ca2+]i (Fig. 2C). The Ca
2+ response to this form of
Fig. 1. Increased Piezo1 expression in IL-1α–treated porcine chondrocytes and human osteoarthritic cartilage. (A) PIEZO1 mRNA level in control and IL-
1α–treated porcine chondrocytes. IL-1α increases Piezo1 mRNA levels; the number of independent experiments (= primary chondrocytes from separate joints
were generated) is indicated in bars; a.u., arbitrary units. (B, Left) Representative confocal micrographs of IL-1α–treated porcine chondrocytes, immunola-
beled for PIEZO1. (Right) Significantly increased PIEZO1 protein expression is found in IL-1α–treated porcine chondrocytes versus control. Numbers in bars
indicate number of cells quantified; three independent cell isolations are shown. (C) Western blot in control and IL-1α–treated porcine chondrocytes. Note
increased PIEZO1 protein expression with IL-1α treatment versus control, β-tubulin not regulated. The upper panels show representative immunoblots (see SI
Appendix, Fig. S1 for full blot), and the lower shows bar diagram densitometric quantitation, normalized for β-tubulin; the number of independent ex-
periments is indicated in bars. (D, Left) Representative confocal micrographs of healthy and osteoarthritic human chondrocytes; PIEZO1-specific immuno-
labeling of chondrocytes in human cartilage tissue (see also SI Appendix, Fig. S2 for antibody validation using PIEZO1−/− cells) (Scale bar, 10 μm). (Right)
Relative expression level PIEZO1 in healthy and OA chondrocytes. The numbers in bars indicate the number of cells quantified; five independent human
cartilage preparations are shown. (E) IL-1α–treated porcine chondrocytes show different Ca2+ dynamics in response to application of the PIEZO1-selective
activating small molecule, Yoda-1 (Left). In this Ca2+ dynamics over time, note accelerated onset and then plateau in the IL-1α–treated cells versus protracted
influx in control chondrocytes, indicative of an enhanced PIEZO1-mediated Ca2+ signaling under inflammatory conditions. (Right) Bar diagrams illustrate
quantitation of the speed of onset of the Ca2+ transient; note more rapid onset under condition of IL-1α–mediated inflammation. The increased potency of 10
μMYoda-1 versus 5 μM Yoda-1 is apparent as well; one independent cell isolation with 24 cells per experimental group. Bars represent mean ± SEM; for group
comparison: t test for B and C; one-way ANOVA, Tukey’s post hoc test for A; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 significantly different from
control. (Scale bars in A and D, 10 μm.)
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Fig. 2. Proinflammatory IL-1α signaling alters Ca2+ dynamics in porcine articular chondrocytes. (A, Left) A schematic diagram of the setup; (Right) repre-
sentative ratiometric Ca2+ images of IL-1α–treated chondrocytes. (B) Resting cytosolic Ca2+ concentrations of primary articular chondrocytes are significantly
increased when exposing cells to IL-1α. The numbers in bars indicate independent experiments. (C, Left) A schematic diagram of the setup; AFM probe (flat,
tipless) compresses single cells cyclically every 10 s. (Right) Ca2+ concentrations in response to cyclical compression. Loading starts at arrow-marked time point.
Representative Ca2+ transients are shown: (Top) control, (Bottom) IL-1α–treated chondrocytes. (D) Mechanical-compression–induced Ca2+ transients are sig-
nificantly increased when exposing primary chondrocytes to IL-1α. The numbers in bars indicate numbers of transients (increase in [Ca2+]i over resting [Ca2+]i)
measured; the number of cells stimulated were 16, 23, 31, and 16 from four independent cell isolations. (E) Resting [Ca2+]i of chondrocytes that were treated
with IL-1α (1 ng/mL) and inhibitors of Piezo (GsMTx4 2 μM/dynasore 5 μM), TRPV4 (GSK205 25 μM), and VGCC (verapamil 0.5 μM). Resting [Ca2+]i that is
significantly elevated by exposure to IL-1α is significantly reduced below control values when inhibiting Piezo but not decreased by inhibition of TRPV4 or
VGCC. The numbers in bars indicate independent experiments, with numbers of cells examined being 855, 457, 385, 387, and 153. (F) Resting [Ca2+]i of
chondrocytes subjected to Piezo1 knockdown via specific siRNA. Note again the significant increase of resting [Ca2+]i when treating with IL-1α (1 ng/mL), as in
E. This significant increase is absent when inhibiting Piezo1 function by transfection with Piezo1-specific siRNA (see SI Appendix, Fig. S4 for demonstration of
effective knockdown of Piezo1); three independent experiments were performed with total numbers of cells indicated in bars. (G) Experimental groups as in
E, but mechanical-compression–evoked Ca2+ dynamics were measured as in C and D. Note that significant IL-1α–evoked Ca2+ increase is significantly atten-
uated when inhibiting Piezo, but, again, there was no decrease when inhibiting TRPV4. Remarkably, there was a complete elimination of the IL-1α–evoked
Ca2+ increase when inhibiting VGCC, in striking contrast to effects of VGCC on resting [Ca2+]i (E). The numbers indicate numbers of transients measured; as in
D, respective number of cells was 3, 4, 4, 3, and 3. (H) Experimental setup as in G and measurement of mechanical-compression–evoked Ca2+ dynamics. We
observed a significant IL-1α–mediated Ca2+ increase, which was completely absent with Piezo1 knockdown (as in F); three independent experiments were
performed with the total numbers of cells indicated in bars. Bars represent mean ± SEM; for group comparison, B, D, E, and F: one-way ANOVA, Tukey’s post
hoc test; *comparison IL-1α versus control, #comparison IL-1α plus treatments versus IL-1α. */#P < 0.05, **/##P < 0.01, ***/###P < 0.001, ****/####P < 0.0001,
significantly different between groups. See SI Appendix, Fig. S2D for subpanels S2D, S2F, and S2H with bar diagrams and all data points.
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mechanical load was also significantly amplified with exposure to
IL-1α, again showing an appreciable response to IL-1α at 0.1 ng/
mL (∼80% increase), with no further increase at 1 and 10 ng/mL
(Fig. 2D) (25, 26), again an exquisite sensitivity to IL-1α in
keeping with observations for basal steady-state [Ca2+]i. Thus,
IL-1α as an inflammatory signal, even at subnanomolar con-
centrations as is likely in early stages of OA development, makes
articular chondrocytes more sensitive to dynamic mechanical
compression at a high but physiologically relevant force of
300 nN.
We next examined the mechanism underlying this Ca2+ sen-
sitization. Steady-state [Ca2+]o was attenuated by GsMTx4
combined with dynasore (GsDy), a combination previously shown
to inhibit Piezo channels in articular chondrocytes (19, 27, 28). We
observed no effect on [Ca2+]i by inhibition of the chondrocyte
mechanosensitive channel TRPV4 with selective inhibitor
GSK205, or inhibition of voltage-gated Ca2+ channels (VGCC)
with verapamil, also expressed in chondrocytes (Fig. 2E).
Chemical inhibition of Piezo channels with GsMTx4 combined
with dynasore can possibly have off-target effects to contribute to
the observed effect. We therefore knocked down Piezo1 with
small-interfering RNA (siRNA). Using a knockdown strategy
that we employed previously (19), we again observed effective
reduction of Piezo1 expression in articular chondrocytes with
specific Piezo1-targeting siRNA versus control, both in the na-
tive state and in IL-1α–mediated inflammatory signaling (SI
Appendix, Fig. S3). When using this approach to inhibit function
of Piezo1, in lieu of GsMTx4 combined with dynasore, we con-
firmed and extended our initial findings, namely that IL-
1α–mediated increase of basal steady-state [Ca2+]o in articular
chondrocytes depends on Piezo1 (Fig. 2F). We then asked this
same question for the mechanical-load–induced Ca2+ response.
Interestingly, the mechanical-load–induced Ca2+ response was
also dependent on PIEZO1, as shown by strong reduction of the
increase in [Ca2+]i by GsMTx4/dynasore (Fig. 2G). Again, this
finding was also confirmed and extended by our Piezo1 siRNA-
mediated approach (Fig. 2H). These findings indicate that in-
creased expression of Piezo1 in IL-1α–mediated inflammation
was responsible for baseline steady-state [Ca2+]i increase as well
as the mechanical-load–evoked [Ca2+]i increase. TRPV4 was not
involved in either condition. We noted with great interest that
VGCC were also key for the mechanical-load–evoked [Ca2+]i
increase, in clear contrast to these channels’ lack of contribution
to increased baseline steady-state [Ca2+]i. Therefore, the mechanical-
load–evoked [Ca2+]i increase relies on both PIEZO1 and VGCC,
potentially functioning as a Ca2+-amplification mechanism of
directly mechanically activated PIEZO1 channels, a finding
consistent with our earlier characterization of PIEZO-mediated
mechanotransduction in chondrocytes (19). This is not the case
without mechanical load, where increased baseline steady-state
[Ca2+]o relies solely on increased expression of PIEZO1 evoked
by inflammatory IL-1α signaling, consistent with studies sug-
gesting that low levels of Ca2+ permeation through PIEZO1 are
present at resting membrane tensions due in part to cytoskeletal
forces (29–31). Taken together, increased Piezo1 expression
evoked by IL-1α profoundly changes the basal function of ar-
ticular chondrocytes by increasing the steady-state baseline
[Ca2+]o by >30%. Increased Piezo1 expression in turn makes
these cells hypersensitive to cyclic mechanical loading with
mildly injurious stimuli, resulting in additional Ca2+ influx.
Furthermore, VGCC function together with PIEZO1 only under
direct deformational mechanical loading in the form of a me-
chanical stress amplification mechanisms, not at resting state.
Piezo1 Increased Expression and Enhanced Function Rarefies F-Actin,
Makes Chondrocytes Vulnerable to Mechanical Injury. We next hy-
pothesized that inflammatory signaling in articular chondrocytes
might exert an effect on the cytoskeleton, the subcellular substrate
of physical stiffness (modulus) of the cell, thus protecting or ex-
posing chondrocytes to increased strain resulting from the thou-
sands of cyclic mechanical loads each day that chondrocytes in
weight-bearing joints undergo. We used phalloidin staining of
porcine chondrocytes to visualize filamentous actin (F-actin) be-
cause force transmission through F-actin is an essential mechano-
transduction process in chondrocytes (Fig. 3A) (32, 33). We found
that F-actin was significantly reduced in IL-1α–exposed chon-
drocytes (Fig. 3B). If Piezo signaling was inhibited with GsMTx4/
dynasore, F-actin was restored. Again, we observed results sim-
ilar to inhibition of Piezo signaling with GsMTx4/dynasore when
knocking down Piezo1 with siRNA (Fig. 3C). In view of this
finding, we asked whether selective activation of Piezo1 with
small molecule, Yoda-1, would also impact chondrocytes’ F-actin
labeling pattern. We generated affirmative results (Fig. 3D), in-
dicating that Piezo-mediated Ca2+ influx suffices to rapidly affect
cytoskeletal organization of the F-actin cytoskeleton of articular
chondrocytes.
These results indicate that Ca2+ influx through up-regulated
PIEZO1 leads to readily apparent changes of the chondrocytic
cytoskeleton, namely a rarefication of F-actin. We did not find
similar regulation of β-tubulin (SI Appendix, Fig. S4), nor did we
see β-actin mRNA or total chondrocytic β-actin protein down-
regulated in response to inflammatory IL-1α signaling (SI Ap-
pendix, Fig. S5). Thus, the F-actin rarefication in response to
increased expression of PIEZO1 occurs at the level of intracel-
lular protein processing and aggregation, not gene expression of
β-actin. With its subplasmalemmal localization, F-actin provides
structure and mechanical stability to the spherical chondrocytes
upon compression.
We next wanted to verify this concept in human OA cartilage
and found that F-actin was also significantly reduced in OA ar-
ticular chondrocytes, with F-actin rarefication appearing very
similar to that observed in IL-1α–treated porcine articular
chondrocytes (Fig. 3E).
We therefore investigated the influence of IL-1α on the me-
chanical properties and force-deformation behavior of porcine
chondrocytes. Exposure to IL-1α led to significantly increased
cellular deformation in response to the same magnitude of me-
chanical loading, a result of a decreased cellular modulus (Fig. 3F).
This phenomenon translates to increased cellular mechanical
strain and potentially microtrauma upon compression. When
inhibiting Piezo signaling with GsMTx4/dynasore, the cellular
modulus and force-deformation properties reverted to control
levels absent IL-1α. This finding, together with the PIEZO1-
regulated F-actin polymerization, indicates that excess Ca2+ en-
tering the chondrocyte via over-expressed PIEZO1, upon mechan-
ical load, decreases cellular mechanical stiffness of chondrocytes
due to rarefied F-actin in the cortical region of the cell. Decreased
cellular rigidity will facilitate cellular mechanical microtrauma and
thus increase likelihood of healthy chondrocytes transitioning
into a degenerated OA phenotype. Importantly, both F-actin
rarefication and decreased cellular rigidity in response to inflam-
matory IL-1α signaling were completely reversible when inhibiting
Piezo signaling.
IL-1α Signaling in Chondrocytes Causing Piezo1 Increased Expression
and Enhanced Function: from Membrane to Nucleus. Based on these
findings, we next investigated signal transduction from membrane-
bound IL-1 receptor (IL1R) via intracellular cytoplasmic signaling
to nuclear transcriptional mechanisms that regulate the PIEZO1
gene in articular chondrocytes in response to IL-1α. Since IL-1α
will engage the IL-1 receptor type 1 (IL-1RI), known to be
expressed by chondrocytes (6, 11), we assessed cellular signal
transduction that up-regulates expression of PIEZO1 by using a
candidate approach. We tested MAP-kinases, known to be
downstream of IL-1RI and downstream kinase, MKK3/6, namely
MEK-ERK, JUN, p38, and AKT-PI3K. Of these, only chemical
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inhibitors of p38-MAP kinase attenuated PIEZO1 mRNA ex-
pression in porcine articular chondrocytes when exposed to
IL-1α (Fig. 4A). Inhibiting the other kinases had no effect. In
support, the phosphorylated isoform of p38 was significantly
increased in response to IL-1α stimulation, whereas its total
protein abundance was unchanged (Fig. 4B). Phosphorylated p38
is known to traffic to the nucleus to regulate gene expression (34,
35). To identify transcription factors (TFs) that can up-regulate
PIEZO1 in articular chondrocytes, we conducted a delimited TF
screening experiment. We found 19 TFs to be up-regulated in
porcine articular chondrocytes in response to IL-1α out of a total
of 96 assessed TFs (Fig. 4C). We next analyzed PIEZO1 regu-
latory DNA sequences from 2,000 base pairs (bp) upstream of
the transcriptional start site to 500 bp downstream of the tran-
scriptional start site (TSS) in human, cow, and chimpanzee.
Using the MULAN DNA sequence analysis program, we gen-
erated predicted binding sites present in all three species tested
(SI Appendix, Fig. S6). We further interrogated ATF2/CREBP1
Fig. 3. Rarefied F-actin cytoskeleton in IL-1α–exposed porcine articular chondrocytes and human OA cartilage. (A) Representative confocal fluorescent
micrographs (confocal slice) of porcine articular chondrocytes; cytoskeleton with F-actin is visualized. (B) Quantitation of fluorescence intensity (arbitrary
units, a.u.) of F-actin (phalloidin labeling); also see Materials and Methods and SI Appendix, Fig. S1. IL-1α exposure significantly diminished F-actin, and Piezo
inhibition with GsMTx4/dynasore completely rescued the rarefication of the F-actin network. The numbers indicate the number of cells analyzed, with three
independent isolations of primary chondrocytes for each group. (C) Quantitation of fluorescence intensity of F-actin as in B. IL-1α exposure significantly
diminished F-actin, and Piezo1-targeting siRNA significantly attenuated the rarefication of the F-actin network. The numbers indicate the number of cells
analyzed, with four independent isolations of primary chondrocytes for each group. Representative confocoal fluorescent micrograph (z-stack) is shown
below. (D) Quantitation of fluorescence intensity of F-actin as in B. Short-term treatment with Piezo1-activating compound Yoda-1 (10 μM, 30 min) signif-
icantly diminished F-actin. The numbers indicate the number of cells analyzed, with four independent isolations of primary chondrocytes for each group.
Representative confocoal fluorescent micrograph (z-stack) is shown below. (E) Representative confocal fluorescent micrographs of human cartilage (confocal
slice), healthy (normal) versus osteoarthritic (OA); cytoskeleton with F-actin is visualized. F-actin was significantly decreased in OA. The numbers indicate
number of cells analyzed. (F) Strain of control, IL-1α–treated, and IL-1α/GsMTx4/dynasore–treated porcine chondrocytes. IL-1α–treated cells (1 ng/mL) have
significantly higher strain than vehicle-treated cells. Note complete restitution to lower strain when inhibiting Piezo with GsMTx4/dynasore in IL-1α–treated
chondrocytes. The numbers indicate number of cells analyzed from three independent isolations of primary chondrocytes for each group. The bars represent
mean ± SEM; for group comparison, B, C, and E: one-way ANOVA, Tukey’s post hoc test; *comparison IL-1α versus control, #comparison IL-1α plus GsMtx4/Dyn
versus IL-1α. */#P < 0.05, **/##P < 0.01, and ***/###P < 0.001, significantly different between groups. Group comparison D: t test; *P < 0.05, ****P < 0.0001,
significantly different between groups. (Scale bars in A, C, D, and E, 10 μm.)
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Fig. 4. Identification of IL-1α–induced signal transduction that results in increased PIEZO1 gene expression by delimited screening in porcine articular
chondrocytes. (A) Inhibitors of p38 MAP-kinase significantly attenuated IL-1α–induced PIEZO1-mRNA increase in primary chondrocytes (IL-1α 1 ng/mL for 3 d,
for all panels) but not inhibitors of MAP-kinases, JNK, MEK-ERK, and PI3K. (B) Western blot analysis of p38 phosphorylation indicates a significant increase of
phospho-p38; total p38 does not change. (C) Starting with 96 TFs, their activation was assessed in response to IL-1α treatment; increased x-fold over baseline,
ranked, and top 25 are shown here. Note the green dotted line at 4×, with 19 of the top 25 TFs ≥4. Below the bar diagram, labeled “MULAN”, note binary
score (+/−) indicating whether the respective TF was found to have a predicted binding site in the proximal PIEZO1 promoter (see E, also SI Appendix, Fig. S6)
using MULAN TF-binding prediction program. Indicated below, labeled “Inhibitor,” is whether the respective TF can be inhibited with a well-established
selective small-molecule inhibitor compound. The two red arrows point toward the two TFs that fulfill all criteria, ATF2 and HNF4. (D) TFs that impact IL-
1α–induced PIEZO1-mRNA increase were identified using selective compounds. HNF4 and ATF2/CREBP (the latter having the same DNA binding site as ATF2,
known to form TF complexes) were confirmed as relevant; HIF, NFAT, and NFkB were not found to be involved. Inhibitors of ATF2/CREBP1 and HNF4 sig-
nificantly attenuated PIEZO1-mRNA increase. The dose–response relationship of ATF2/CREBP1 inhibitor CBP30 showed a Pearson correlation coeffi-
cient = −0.85, P = 0.0008, indicating a significant correlation. The respective metrics for HNF4 inhibitor BI6015 were Pearson correlation coefficient = −0.86,
P = 0.0014, also indicative of a signification correlation. (E) A schematic of predicted binding sites of HNF4 and ATF2/CREBP1 TFs in the proximal PIEZO1
promoter, as revealed by the bioinformatics platform MULAN. Please see also SI Appendix, Fig. S6. (F) Direct CREBP1 binding to the PIEZO1 promoter was
assessed by chromatin immunoprecipitation followed by qPCR. Note fivefold increased abundance with IL-1α signaling versus control, indicative of direct
CREBP1 binding to the PIEZO1 proximal promoter site indicated in E (yellow bar, between 0 and +500 PIEZO1 promoter). For A, B, D, and F, the numbers in
bars indicate number of independent isolations of primary chondrocytes. The bars represent mean ± SEM; for group comparison B and F, t test, *P < 0.05; for
group comparisons A and D, one-way ANOVA, Tukey’s post hoc test; *comparison IL-1α versus control, #comparison IL-1α plus treatment versus IL-1α.
*/#P < 0.05.
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and HNF4 because they identified from the 96-TF screen and
were ≥4× up-regulated, they were present in all species’ proximal
PIEZO1 promoter in MULAN, and they can be reliably inhibi-
ted with well-established selective small molecule inhibitors
(Fig. 4C and SI Appendix, Fig. S6). We selected HIF, NFAT, and
NF-κB as controls, expected not to regulate PIEZO1 in response
to IL-1α because they were not picked up by MULAN or the
96-TF screen. Of these TFs, in porcine articular chondrocytes,
inhibition of ATF2/CREBP1 and HNF4 significantly and dose
dependently attenuated the increase of PIEZO1 expression in
response to IL-1α (Fig. 4D). As expected, inhibition of HIF, NFAT,
and NFκB had no effect on PIEZO1 expression. Of the TFs that we
identified to enhance expression of PIEZO1, ATF2 and CREBP1
are family members known to bind to a consensus DNA binding site
and to form protein–protein complexes that also include p38 (36,
37). HNF4 has also been demonstrated to be part of such multi-
protein complexes by binding to p38 and CREB (38, 39). Based on
the MULAN bioinformatics analysis (Fig. 4E and SI Appendix, Fig.
S6), we predicted direct binding of CREBP/ATF2 and HNF4 to the
proximal PIEZO1 promoter to regulate the PIEZO1 gene rather
than indirect regulation through other transcriptional enhancer or
derepression mechanisms. We examined CREBP1 binding to the
PIEZO1 promoter by chromatin immunoprecipitation (ChIP)-
qPCR using DNA extracted from porcine articular chondrocytes
after subjecting these cells to immunoprecipitation for CREBP1
(Fig. 4F). We amplified sequences from the predicted ATF2/
CREBP1 binding site in the vicinity of the PIEZO1 TSS. When
immunoprecipitating with anti-CREBP1, we detected a robust ∼3×
increase of PIEZO1-promoter–amplified DNA than with control
antibody, indicating direct binding of CREBP1 to the probed site.
Given the known interaction between CREBP1, ATF2, and HNF4,
we regard it as highly likely that ATF2 and HNF4 also participate in
a multiprotein enhancer complex that directly binds to the proximal
PIEZO1 promoter and up-regulates PIEZO1 gene expression.
Discussion
Taken together, our findings demonstrate a signaling mechanism
from membrane to nucleus, from the IL-1α–IL-1RI complex,
and then via MKK3/6 to p38 MAP-kinase (as previously estab-
lished), phospho-p38 to nuclear signaling of TF CREBP1, which
binds PIEZO1 regulatory DNA sequences together with TFs
HNF4 and ATF2 (Fig. 5). These TFs then enhance PIEZO1
gene expression. This signaling cascade leads to overexpression
of Piezo1 in articular chondrocytes in response to inflammatory
signaling. Overexpressed PIEZO1 channels in turn cause in-
creased resting [Ca2+]i and increased mechanical-stress–evoked
Ca2+ increase, indicative of mechanical hypersensitivity, “hyper-
mechanotransduction” (40, 41). Increased resting [Ca2+]o, via
PIEZO1, leads to rarefication of F-actin which decreases the
stiffness of the chondrocytes. This results in increased cellular
deformation in response to mechanical loading. This phenomenon
represents a detrimental feed-forward mechanism, as increased
deformation elevates the opening probability of mechanosensitive
PIEZO channels, amplified by PIEZO1 being overexpressed. We
speculate that the rarefied F-actin cytoskeleton enhances cyto-
plasmic availability of p38 for phosphorylation, which happens
after activation of IL-1RI, based on previous demonstration of the
F-actin cytoskeleton influencing gene expression (42, 43).
PIEZO1 gain-of-function mutations have been reported in
humans, typically associated with an erythrocyte disorder, xero-
cytosis, an anemia phenotype, and also a resistance to malaria in
Africans (44, 45). Increased or premature OA has not been
reported in these cases. We believe that a genetically encoded
gain-of-function of PIEZO1 can set up altered homeostatic
regulation in Piezo1-expressing cells because the impact of the
gain-of-function channel is present throughout all stages of de-
velopment. Joint-inflammation–evoked increased gene expres-
sion and function of Piezo1 in articular chondrocytes forces an
adaptation on the cell that might well be maladaptive, whereas in
the case of PIEZO1 gain-of-function mutations, there is no
adaptation to it.
Another interesting spotlight is cast on our study by the pre-
vious investigation of Blythe et al., who reported that Piezo1
activation leads to production of inflammatory cytokine IL-6 in
cardiac fibroblasts via p38 MAP-kinase signaling, thus perhaps
involved in cardiac remodeling in response to mechanical stimuli
(46). This paper and ours report feed-forward mechanisms;
however, conceptually, this study (46) has a starting point of
Piezo1 activation by mechanical stimuli, whereas we are looking
at inflammatory signaling by IL-1α as starting point, downstream
of it increased expression of Piezo1 which then facilitates hyper
mechanotransduction and subsequent cellular damage via repeat
Fig. 5. Feed-forward pathogenesis of OA relying on chondrocytic inflammatory signaling, which results in Piezo1 increased function. A schematic of our
findings and proposed OA pathogenetic mechanism. Signaling hubs and their consequences, upon activation as we demonstrate, are shown as a sequence 1
to 6. Shown in black letters, 1 to 6 is supported by our findings and known background. We interpret the result as “hypermechanotransduction & increased
cellular damage,” in purple and speculate, in blue, that a loosened/rarefied F-actin may enhance p38 phosphorylation by making p38 more available
for kinases.
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microtrauma (Fig. 5) at the heart of the feed-forward mechanism
that we describe here.
Also of note, our study focuses on inflammatory reprogram-
ming mechanisms of articular chondrocytes. We document in-
creased gene expression and function of Piezo1 after 72 h of
exposure to IL-1α. Early changes in response to IL-1α might
differ how they can impact the F-actin cytoskeleton (47). How-
ever, we wish to emphasize that long-term reprogramming likely
has increased disease relevance for OA, a long-term chronic
process. Our findings are interesting when viewed against cyto-
skeletal sequalae observed with Piezo1 loss-of-function in non-
skeletal cells (48, 49). In these elegant studies, though, there was
no inflammatory injury.
In summary, we have identified a pathogenic feed-forward
signaling and gene-regulatory mechanism in weight-bearing ar-
ticular chondrocytes. This mechanism appears relevant for the
pathogenesis of OA because it is a molecular mechanism linking
inflammatory signaling with resulting hyper mechanotransduction
via up-regulated PIEZO1 expression and function. As one result
of PIEZO1 overexpression and resulting excess steady-state Ca2+,
we found cytoskeletal changes of F-actin that facilitate cellular
mechanotrauma, predisposing and contributing to chondrocyte
dedifferentiation and degeneration as the foundation of the irre-
versible cartilage damage in “degenerative”OA. Breaking through
this feed-forward mechanism therapeutically provides a rational
target in the quest for OA disease-modifying therapies.
Materials and Methods
Porcine Chondrocyte Isolation and IL-1α Treatment. Primary articular chon-
drocytes were harvested from articular cartilage of the femoral condyles of
skeletally mature (2 to 3 y old) female pigs as described in ref. 19. The isolated
chondrocytes were seeded on 12 mm coverslips and tissue culture plates. The
next day, chondrocytes were exposed to the proinflammatory cytokine, IL-1α
(R&D Biosystems), at 0, 0.1, 1, and 10 ng/mL for 2 to 3 d (25, 26). Ca2+ im-
aging, mechanical stimulation experiments, and RT-qPCR were performed
approximately 60 to 72 h after IL-1α treatment. Culture medium was
changed every 2 d.
Measurement of Steady-State Intracellular Ca2+ Concentration [Ca2+]o. To
measure cytosolic [Ca2+] level, chondrocytes on coverslips were loaded with
Ca2+-sensitive Fura-2-AM dye (2 μM for 40 min; Invitrogen) and imaged using
a ratiometric Ca2+ imaging platform (Intracellular Imaging, Setup 1 in
Fig. 2A) as described in ref. 19. Cytosolic [Ca2+] was determined using
Incytim-2 software (Intracellular Imaging), based on 340:380 ratio and cali-
bration of standard solutions, measuring [Ca2+]i in individual chondrocytes.
Measurement of Compression-Induced Ca2+ Transients. Mechanically induced
Ca2+ influx of individual chondrocytes was measured using a custom-built
AFM/Ca2+ setup consisting of the atomic force microscope (Bioscope; Veeco
or MFP-3D; Asylum) and a ratiometric Ca2+ imaging microscope (Intracellular
Imaging; Fig. 2C) as described in ref. 19. Briefly, AFM probe (flat, tipless)
compresses single cells cyclically with trigger force of 300∼500 nN every 10 s
for 2 min, and the cytosolic [Ca2+] transients in response to cyclical com-
pression mechanics were measured during the loading (1 ∼2 frames). Spring
constants of the tipless cantilever were 0.5 to 14 N/m (Novasan or Bruker Probes),
the compression rate was 1 to 2 μm/s, and the experiments were conducted at
37 °C. The five maximum Ca2+ influx of each chondrocyte were determined
([Ca2+]max), and influx was determined as Δ[Ca2+] = [Ca2+]max − [Ca2+]o.
Measurement of Intracellular Ca2+ Concentration Using Fluorescent Imaging
Plate Reader Assay. Our approach followed previously reported methods
(50, 51). Isolated chondrocytes were plated in a 96-well plate at 30,000 cells
per well for 12 h. Media were then supplemented with either 0 ng/mL or
10 ng/mL porcine IL-1α and incubated for 72 h. Cellular response in each well
was measured via fluo-4 intracellular calcium dye using the fluo-4 NW cal-
cium assay kit (Molecular Probes) according to manufacturer’s directions.
Intracellular Ca2+ using a fluorescent imaging plate reader. PIEZO1 stimu-
lation was performed by supplementing Yoda-1 at 5 μM or 10 μM. A vehicle
(dimethyl sulfoxide (DMSO), 0 μM Yoda-1) control group was also run to
measure the baseline intracellular Ca2+ levels.
Treatment with Compounds and GsMTx4. Chondrocytes were treated with
compounds for 1∼2 h during Fura-2-AM loading process: GsMTx4 peptide (2
μM, provided by Philip Gottlieb, State University of New York at Buffalo),
dynasore (5 μM, Tocris), and verapamil (0.5 μM, Sigma). To identify signal
transduction mechanisms and transcription factors that regulate IL-
1α–induced Piezo1 expression, inhibitors were coincubated with IL-1α
(1 ng/mL) for 3 d. Inhibitors used were SGCCBP30 (10 to 50 μM, Cayman
Chemical), BI6015 (10 to 50 μM, Cayman), YC-1 (10 μM, Cayman), nuclear
factor of activated T cells (NFAT) inhibitor (10 μM, Cayman), SB203580 (10
μM, VWR), SB239063 (10 μM, Sigma Aldrich), LY294002 (10 μM, VWR), PI828
(10 μM, Fisher Scientific), SP600125 (10 μM, VWR), and U0126 (10 μM, VWR).
mRNA Expression in Isolated Chondrocytes by RT-qPCR. After treatments,
chondrocytes’ total RNA was extracted using TRIzol for RT-qPCR. PCR spec-
ificity was confirmed by gel electrophoresis and dissociation curve analysis.
GAPDH or 18S were used as a housekeeping gene for normalization, and the
gene-under-study mRNA level was quantified using the 2-ΔΔCT method, as in
refs. 52 and 53, with normalization to control as in refs. 54 and 55.
Immunocytochemistry. Porcine articular chondrocytes were cultured on glass
coverslips, fixed with 4% paraformaldehyde at 4 °C for 15min, permeabilized
with 2% Triton X-100, and blocked with 5% donkey or goat serum for
30 min. Then, cells were exposed to primary antibodies at 4 °C overnight and
then to fluorescent secondary antibody. Immunolabeling was visualized
using a Zeiss 780 confocal microscope. Anti-PIEZO1 (NBP1-78537, Novus)
was used. Chondrocytes were also labeled with fluorescent Phalloidin
(phalloidin-CF568, Biotium) to visualize F-actin or with BT7R-dylight488
(Thermo Fisher) to visualize β-tubulin and then imaged. A Zeiss 780 con-
focal microscope (Plan Apochromat 40×/1.4 NA oil immersion objective) or a
BX61 Olympus upright microscope (X-Apochromat 40×/1.4 NA oil immersion
objective) equipped with high-resolution charge-coupled device (CCD)
camera and ISEE software (ISEE Imaging Systems) were used. For confocal
laser scanning microscopy, confocal slices or z-stacks were acquired follow-
ing refs. 56 and 57.
Circular chondrocytes were selected as region-of-interest (ROI), and their
ROI integrated density was determined using ImageJ, subtracted for non-
cellular background in immunocytochemistry applications, yielding individ-
ual metric data points per cell, see also SI Appendix, Fig. S1.
Immunohistochemistry. Paraffin-embedded tissue sections (15 μm) of human
articular cartilage from healthy (n = 5) and osteoarthritic (n = 6) anonymized
donors were used (Articular Engineering). Sections were immunolabeled
with Piezo1-antibody (NBP1-78537) followed by fluorescent secondary an-
tibody (Alexa Fluor 594) and imaged. For F-actin staining, sections were la-
beled with fluorescent Phalloidin (phalloidin-CF350, Biotium) and imaged
under a Zeiss 780 confocal microscopy platform (Plan Apochromat 40×/1.4
NA oil immersion objective), again acquiring z-stacks as described above.
Western Blot.We followed standard methods (56, 58). Briefly, cells were lysed
with CHAPS buffer and separated on a 10% sodium dodecyl sulfate (SDS)
polyacrylamide gel and then transferred to polyvinylidene difluoride (PVDF)
membrane filters (0.45 mm pore; Millipore). Membranes were blocked with
5% dry milk, protein levels were detected by using primary antibodies of
PIEZO1 (Proteintech, 15939-1-AP), p38 (Cell Signaling, #8690), phospho-p38
(Cell Signaling, #4511) secondary antibody (Jackson Immuno Research, anti-
rabbit peroxidase-conjugated); and chemoluminescence substrate
(ECL-Advance, GE Healthcare). Abundance was quantified using ImagePro
Plus software.
siRNA Transfection to Knock-Down Piezo1. As described in ref. 19, isolated
chondrocytes were immediately nucleofected with siRNA to target the Sus
scofra Piezo1 mRNA (pool of siRNAs with the following sense strands: 5′-CAG-
CGAGAUCUCGCACUCCAUCUU-3′, 5′-UACGACCUGCUGCAGCUCCUGUU-3′,
and 5′-ACCCGCUGGCCAUGCAGUUCUUUU-3′ all synthesized from Dharma-
con) or a nontargeting construct siRNA (siNTC, Invitrogen). Nucleofection
was done with the Lonza 4D-Nucleofector according to manufacturer’s
guidelines using the ER-100 protocol. Nucleofected cells were plated on glass
coverslips overnight in fetal bovine serum (FBS)–containing feed media
(without Pen-strep) before changing media to contain either 0 or 1 ng/mL
porcine IL-1α. Cells were left incubating for 48 h. PIEZO1 mRNA levels were
quantified by RT-qPCR.
Chondrocyte Strain Measurement. To measure the cellular strain applied with
AFM, cells were plated on coverslip glass and supplemented with IL-1α,
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IL-1α+GsMTx4+dynasore, or vehicle control as described above. To measure
deformation and strain of cells under each treatment, we used an AFM to
apply a 25 nN load to each tested cell. After loading each cell, the coverslip
adjacent to the cell was also loaded to measure the baseline position. Load
curves for each cell and coverslip load consist of the z-position (height) and
AFM cantilever deflection. AFM cantilever deflection was used to estimate
the applied load using the cantilever stiffness. A custom-written MATLAB
code, based on the work of Chang et al. (59), was used to determine the
contact point of the cantilever with the cell (zcp), the contact point of the
cantilever with the coverslip (zcs), and the point at which the cell deformed
under the 25 nN load (zdef). While cells are generally considered to be
complex materials and modeled under mixture material frameworks con-
sisting of viscoelastic and elastic components, this code approximates the
cellular material response closely surrounding the contact point as an elastic
material. Using a Hertzian-contact–type framework, the contact point is
approximated based on this assumption. The nominal cellular strain per-
centage, e, was computed as deformation of the cell to the load divided by
the height of the cell, e = (zcp − zdef)/(zcp − zcs)×100. Our MATLAB script
(adapted from ref. 59) is shared as freeware.
Discovery of Transcription Factors Regulating the IL-1α–Induced Piezo1
Expression by Transcription Factor Array. Nuclear extracts of porcine chon-
drocytes were prepared using Nuclear Extraction Kit (SK-0001, Signosis), and
then the transcription factor (TF) Activation Profiling Plate Array II (FA-1002,
Signosis) was used to monitor 96 TFs simultaneously, according to
manufacturer protocol.
Briefly, the nuclear extracts were incubated with biotin-labeled probes
which were designed based on the consensus sequences of TF binding sites.
The TF-probe complexes were purified, and then the bound probes were
separated from the complex. The detached probes were hybridized in
96-well plates where each well is specifically coated with complimentary
sequences of the probes. The bound DNA probes are mixed with horseradish
peroxidase (HRP)-Streptavidin conjugates, and the luminescence was read in
microplate luminometer. The luminescence of control and the IL-1α–treated
chondrocytes were compared.
TF Binding Site Analysis by Bioinformatics. TF binding sites within the PIEZO1
promoter were analyzed and predicted using the comprehensive, web-
based Evolutionary Conserved Region Browser (http://ecrbrowser.dcode.
org). The promotor regions of PIEZO1 [−2,000 nt to +500 nt, transcription
start site (TSS) defined as zero] in three different species were aligned, using
high-quality genome sequences with a defined PIEZO1 TSS: human (hg19
Chromosome 16: 88853372-88850872), cow (bostau6 Chromosome 18:
14041407-14039769), and chimpanzee (pantro3 Chromosome 16: 88511045-
88508550). The MULAN TF-binding prediction algorithm, within ecrbrowser,
was run on these three species to identify candidate TF binding sites.
ChIP Assay. ChIP assays were performed using primary articular porcine
chondrocyte nuclear extract, and cell isolation from 4 individual pigs was
conducted. The Magnify ChIP kit (Thermo Fisher) was used according to
manufacturer’s instructions and as described previously (52, 60).
Anti-CRBP1–immunoprecipitated DNA was purified to perform qPCR to
determine the relative abundance of PIEZO1 promoter DNA fragments.
Conserved sequences of cow (bostau6 Chromosome 18: 14041407-14039769,
AC_000175.1) and pig (NC_010448.3) were aligned to generate primers for
ChIP-qPCR. A 103-nucleotide amplicon was generated from the pig PIEZO1
promoter: (CTCCGGATTAAACAGCTCCAGGCAGGAAGC-CCGCCTTCTCCCAGA-
TTGGTCAGGAAGTCCTGATGCAAGTTTGCGCGTTTTCTTTCTCTCTCTCTCTCTCTTT;
CREBP1 binding site is underlined). The sequences of the forward and back-
ward primers are as follows: For-CTCCGGATTAAACAGCTCCA and Rev-
AAAGAGAGAGAGAGAGAGAAAGAAA.
Statistical Analysis. Data are presented as mean ± SEM. Student’s t test or
one-way ANOVA, Tukey’s post hoc test for group-to-group comparisons
were used to determine the statistical significance. For correlation, Pearson’s
correlation coefficient and its P value were calculated. All statistical analysis
was conducted using GraphPad Prism 8.4.
Data Availability. All study data are included in the article and/or supporting
information.
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